Patrick Hossler

Patrick Hossler, Ph.D. has over 15 years of work experience in the pharmaceutical industry. Patrick is currently serving as the Senior Director of Pharmaceutical Development at Ultragenyx since August 2022. Prior to this, they held various roles at TG Therapeutics, Inc. from June 2018 to August 2022, including Senior Director of Biologics CMC. From November 2007 to June 2018, they worked at AbbVie in various roles, ultimately reaching the position of Principal Research Scientist/Associate Director. Their career started at Bristol-Myers Squibb in August 2006 as an Engineer.

Patrick Hossler, Ph.D. earned their Bachelor of Science degree in Chemical/Biochemical Engineering from Rutgers University. Patrick later went on to obtain their Doctor of Philosophy degree in Chemical/Biochemical Engineering from the University of Minnesota.